STOCK TITAN

[8-K] GE HealthCare Technologies Inc. Reports Material Event

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
8-K
Rhea-AI Filing Summary

GE HealthCare Technologies Inc. (GEHC) furnished its third quarter 2025 financial results press release on an 8-K dated October 29, 2025. The press release is included as Exhibit 99.

The Item 2.02 information is furnished, not filed, and is not subject to Section 18 liabilities or incorporated by reference unless expressly stated. GE HealthCare’s common stock trades on Nasdaq under the symbol GEHC.

GE HealthCare Technologies Inc. (GEHC) ha fornito il comunicato stampa sui risultati finanziari del terzo trimestre 2025 in un 8-K datato 29 ottobre 2025. Il comunicato è incluso come Allegato 99.

Le informazioni dell'Item 2.02 sono fornite, non presentate e non soggette alle responsabilità della Sezione 18 né incorporate per rinvio salvo espressa indicazione. Le azioni ordinarie di GE HealthCare sono negoziate sul Nasdaq con il simbolo GEHC.

GE HealthCare Technologies Inc. (GEHC) presentó su comunicado de prensa sobre los resultados financieros del tercer trimestre de 2025 en un 8-K con fecha del 29 de octubre de 2025. El comunicado se incluye como el Anexo 99.

La información del Ítem 2.02 está proporcionada, no presentada y no está sujeta a responsabilidades de la Sección 18 ni incorporada por referencia a menos que se indique expresamente. Las acciones ordinarias de GE HealthCare se cotizan en Nasdaq bajo el símbolo GEHC.

GE HealthCare Technologies Inc. (GEHC)가 2025년 3분기 재무실적 보도자료를 2025년 10월 29일자 8-K에 게재했습니다. 보도자료는 Exhibit 99로 포함되어 있습니다.

Item 2.02 정보는 제공되었으며 제출되지 않음이며 제18조 책임의 적용 대상이 아니거나 명시적으로 나타난 경우에 한해 참조에 의한 통합되지 않습니다. GE HealthCare의 보통주는 나스닥에서 심볼 GEHC로 거래됩니다.

GE HealthCare Technologies Inc. (GEHC) a diffusé son communiqué de presse sur les résultats financiers du troisème trimestre 2025 dans un 8-K daté du 29 octobre 2025. Le communiqué est inclus en tant qu'Annexe 99.

Les informations de l'élément 2.02 sont fournies, non déposées et ne relèvent pas des responsabilités de la Section 18 ni ne sont incorporées par référence, sauf indication explicite. Les actions ordinaires de GE HealthCare se négocient au Nasdaq sous le symbole GEHC.

GE HealthCare Technologies Inc. (GEHC) hat seine Ergebnisse zum dritten Quartal 2025 in einer Pressemitteilung in einer 8-K vom 29. Oktober 2025 veröffentlicht. Die Pressemitteilung ist als Anhang 99 beigefügt.

Die Informationen gemäßig Item 2.02 sind bereitgestellt, nicht eingereicht und unterliegen nicht den Verpflichtungen der Section 18 bzw. sind nicht durch Bezugnahme einbezogen, es sei denn, es wird ausdrücklich angegeben. Die GE HealthCare-Stammaktie wird an der Nasdaq unter dem Symbol GEHC gehandelt.

قدمت GE HealthCare Technologies Inc. (GEHC) بيان النتائج المالية للربع الثالث من عام 2025 في بيان 8-K بتاريخ 29 أكتوبر 2025. ويُدرج البيان الصحفي كمرفق 99.

معلومات العنصر 2.02 مزودة، وليست مقدّمة وليست خاضعة لمسؤوليات القسم 18 أو مدرجة بالمرجعية إلا إذا ورد ذلك صراحة. يتم تداول الأسهم العادية لـ GE HealthCare في ناسداك بالرمز GEHC.

Positive
  • None.
Negative
  • None.

GE HealthCare Technologies Inc. (GEHC) ha fornito il comunicato stampa sui risultati finanziari del terzo trimestre 2025 in un 8-K datato 29 ottobre 2025. Il comunicato è incluso come Allegato 99.

Le informazioni dell'Item 2.02 sono fornite, non presentate e non soggette alle responsabilità della Sezione 18 né incorporate per rinvio salvo espressa indicazione. Le azioni ordinarie di GE HealthCare sono negoziate sul Nasdaq con il simbolo GEHC.

GE HealthCare Technologies Inc. (GEHC) presentó su comunicado de prensa sobre los resultados financieros del tercer trimestre de 2025 en un 8-K con fecha del 29 de octubre de 2025. El comunicado se incluye como el Anexo 99.

La información del Ítem 2.02 está proporcionada, no presentada y no está sujeta a responsabilidades de la Sección 18 ni incorporada por referencia a menos que se indique expresamente. Las acciones ordinarias de GE HealthCare se cotizan en Nasdaq bajo el símbolo GEHC.

GE HealthCare Technologies Inc. (GEHC)가 2025년 3분기 재무실적 보도자료를 2025년 10월 29일자 8-K에 게재했습니다. 보도자료는 Exhibit 99로 포함되어 있습니다.

Item 2.02 정보는 제공되었으며 제출되지 않음이며 제18조 책임의 적용 대상이 아니거나 명시적으로 나타난 경우에 한해 참조에 의한 통합되지 않습니다. GE HealthCare의 보통주는 나스닥에서 심볼 GEHC로 거래됩니다.

GE HealthCare Technologies Inc. (GEHC) a diffusé son communiqué de presse sur les résultats financiers du troisème trimestre 2025 dans un 8-K daté du 29 octobre 2025. Le communiqué est inclus en tant qu'Annexe 99.

Les informations de l'élément 2.02 sont fournies, non déposées et ne relèvent pas des responsabilités de la Section 18 ni ne sont incorporées par référence, sauf indication explicite. Les actions ordinaires de GE HealthCare se négocient au Nasdaq sous le symbole GEHC.

GE HealthCare Technologies Inc. (GEHC) hat seine Ergebnisse zum dritten Quartal 2025 in einer Pressemitteilung in einer 8-K vom 29. Oktober 2025 veröffentlicht. Die Pressemitteilung ist als Anhang 99 beigefügt.

Die Informationen gemäßig Item 2.02 sind bereitgestellt, nicht eingereicht und unterliegen nicht den Verpflichtungen der Section 18 bzw. sind nicht durch Bezugnahme einbezogen, es sei denn, es wird ausdrücklich angegeben. Die GE HealthCare-Stammaktie wird an der Nasdaq unter dem Symbol GEHC gehandelt.

قدمت GE HealthCare Technologies Inc. (GEHC) بيان النتائج المالية للربع الثالث من عام 2025 في بيان 8-K بتاريخ 29 أكتوبر 2025. ويُدرج البيان الصحفي كمرفق 99.

معلومات العنصر 2.02 مزودة، وليست مقدّمة وليست خاضعة لمسؤوليات القسم 18 أو مدرجة بالمرجعية إلا إذا ورد ذلك صراحة. يتم تداول الأسهم العادية لـ GE HealthCare في ناسداك بالرمز GEHC.

GE HealthCare Technologies Inc. (GEHC) 已在2025年10月29日的8-K中提供了其2025年第三季度财务业绩新闻稿。新闻稿作为附件99包含在内。

信息项2.02为已提供,而非提交,且不受第18条的责任约束,除非另有明确说明;也不通过引用纳入。 GE HealthCare的普通股在纳斯达克交易,代码为GEHC

0001932393false00019323932025-10-292025-10-29

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

FORM 8-K

CURRENT REPORT
Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934
Date of Report (Date of earliest event reported) October 29, 2025

GE HEALTHCARE TECHNOLOGIES INC.
(Exact name of registrant as specified in its charter)
 
Delaware001-4152888-2515116
(State or other jurisdiction
of incorporation)
(Commission
 File Number)
(IRS Employer
Identification No.)
   
500 W. Monroe Street, Chicago, IL
 60661
(Address of principal executive offices) (Zip Code)
    
(Registrant’s telephone number, including area code) (833) 735-1139

______________________________________________
(Former name or former address, if changed since last report.)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) 
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:
Title of each class
Trading Symbol(s)
Name of each exchange on which registered
Common stock, par value $0.01 per share
GEHC
The Nasdaq Stock Market LLC
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 or Rule 12b-2 of the Securities Exchange Act of 1934.
Emerging growth company
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards pursuant to Section 13(a) of the Exchange Act.



Item 2.02 Results of Operations and Financial Condition.

On October 29, 2025, GE HealthCare Technologies Inc. (“GE HealthCare”) issued a press release announcing its third quarter 2025 financial results. A copy of this press release is furnished as Exhibit 99 to this Current Report on Form 8-K.

The information furnished pursuant to Item 2.02, including Exhibit 99, shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or otherwise subject to the liabilities under that Section and shall not be deemed to be incorporated by reference into any filing of GE HealthCare under the Securities Act of 1933, as amended, or the Exchange Act, except as expressly set forth by specific reference in such filing.

Item 9.01 Financial Statements and Exhibits.

(d) Exhibits
ExhibitDescription
99
Press release of GE HealthCare Technologies Inc., dated October 29, 2025.
104The cover page of this Current Report on Form 8-K, formatted in Inline XBRL.




SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

  GE HealthCare Technologies Inc.
  
(Registrant)
  
Date: October 29, 2025
 /s/ George A. Newcomb
  George A. Newcomb, Controller & Chief Accounting Officer (authorized signatory)


FAQ

What did GEHC (GE HealthCare) announce in this 8-K?

GE HealthCare furnished a press release announcing its Q3 2025 financial results as Exhibit 99.

When was the GEHC Q3 2025 press release furnished?

On October 29, 2025, with the 8-K reporting the same date as the earliest event.

Which 8-K item covers the GEHC results press release?

Item 2.02, Results of Operations and Financial Condition.

Is the Item 2.02 information considered filed under Section 18?

No. It is furnished, not filed, and not subject to Section 18 liabilities.

What exhibits are included with the 8-K?

Exhibit 99: the press release; Exhibit 104: the cover page formatted in Inline XBRL.

Where is GE HealthCare’s common stock listed and under what symbol?

On The Nasdaq Stock Market LLC under the symbol GEHC.
Ge Healthcare Technologies Inc

NASDAQ:GEHC

GEHC Rankings

GEHC Latest News

GEHC Latest SEC Filings

GEHC Stock Data

34.16B
454.22M
0.27%
87.11%
1.61%
Health Information Services
X-ray Apparatus & Tubes & Related Irradiation Apparatus
Link
United States
CHICAGO